Resistance of Cancer Cells to CTL-Mediated Immunotherapy

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Resistance of Cancer Cells to CTL-Mediated Immunotherapy by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319178073
Publisher: Springer International Publishing Publication: June 20, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319178073
Publisher: Springer International Publishing
Publication: June 20, 2015
Imprint: Springer
Language: English

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

More books from Springer International Publishing

Cover of the book The Path to Post-Galilean Epistemology by
Cover of the book Judgments of Love in Criminal Justice by
Cover of the book Application and Theory of Petri Nets and Concurrency by
Cover of the book Turnpike Conditions in Infinite Dimensional Optimal Control by
Cover of the book Service Orientation in Holonic and Multi-Agent Manufacturing by
Cover of the book Central European Functional Programming School by
Cover of the book Elliptic and Parabolic Equations by
Cover of the book Advances in Swarm Intelligence by
Cover of the book Games and Learning Alliance by
Cover of the book Big Data Management by
Cover of the book Bioinformatics and Biomedical Engineering by
Cover of the book The Encapsulation Phenomenon by
Cover of the book Oscar Wilde and Contemporary Irish Drama by
Cover of the book Political Representation in France and Germany by
Cover of the book Evolution of the Protein Synthesis Machinery and Its Regulation by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy